Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors), >95%, 5 mg
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors), >95%, 5 mg
Angiotensin Converting Enzyme Inhibitors, (ACE Inhibitors) >95%, 5 mg
|
Peptide Name |
CAT# |
Peptide Sequence |
|
Angiotensin Converting Enzyme Inhibitor |
2025-1-1 |
Glp-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro |
|
Angiotensin I Converting Enzyme Inhibitor |
2025-1-2 |
Glp-Gly-Leu-Pro-Pro-Arg-Pro-Lys-Ile-Pro-Pro |
|
Angiotensin I Converting Enzyme Inhibitor |
2025-1-3 |
Glp-Gly-Leu-Pro-Pro-Gly-Pro-Pro-Ile-Pro-Pro |
|
Angiotensin I Converting Enzyme Inhibitor |
2025-1-4 |
Arg-Pro-Gly-Phe-Ser-Pro-Phe-Arg |
ACE inhibitors or angiotensin-converting enzyme inhibitors are a group of small peptides used primarily for the treatment of hypertension (high blood pressure) and congestive heart failure. Originally synthesized from compounds found in pit viper venom, they inhibit angiotensin-converting enzyme (ACE), a component of the blood pressure-regulating renin-angiotensin system.
Product features
Product features
Materials and care
Materials and care
Merchandising tips
Merchandising tips
Share
